Clemens Scherzer

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Translational Genomics of Parkinson’s Disease: Cause, Cures, Diagnostics
Google:
"Clemens Scherzer"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Domínguez-Baleón C, Ong JS, Scherzer CR, et al. (2021) Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study. Scientific Reports. 11: 13980
Dong X, Li X, Chang TW, et al. (2021) powerEQTL: An R package and shiny application for sample size and power calculation of bulk tissue and single-cell eQTL analysis. Bioinformatics (Oxford, England)
Iwaki H, Leonard HL, Makarious MB, et al. (2021) Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource. Movement Disorders : Official Journal of the Movement Disorder Society
Liu G, Peng J, Liao Z, et al. (2021) Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nature Genetics
Tokarew JM, El-Kodsi DN, Lengacher NA, et al. (2021) Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites. Acta Neuropathologica
Huh YE, Ruby Chiang MS, Locascio JJ, et al. (2020) β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology
Bakshi R, Macklin EA, Hung AY, et al. (2020) Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510
Dong X, Liao Z, Gritsch D, et al. (2018) Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nature Neuroscience
Dong X, Liao Z, Gritsch D, et al. (2018) Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nature Neuroscience
Mittal S, Bjørnevik K, Im DS, et al. (2017) β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. Science (New York, N.Y.). 357: 891-898
See more...